Zarodex Therapeutics Limited, London

Zarodex Therapeutics Limited is a private limited company. Registered at 71 Kingsway, London WC2B 6ST, the above-mentioned 2 years old business was incorporated on 2017-07-26 and is officially classified as "research and experimental development on biotechnology" (Standard Industrial Classification: 72110).
4 directors can be found in the business: Kate B. (appointed on 28 February 2018), Alexander L. (appointed on 28 February 2018), Houman A. (appointed on 26 July 2017).
About
Name: Zarodex Therapeutics Limited
Number: 10885695
Incorporation date: 2017-07-26
End of financial year: 30 September
 
Address: 71 Kingsway
London
WC2B 6ST
SIC code: 72110 - Research and experimental development on biotechnology
Company staff
People with significant control
Houman A.
26 July 2017
Nature of control: 50,01-75% shares
50,01-75% voting rights
right to appoint and remove directors
Duncan M.
26 July 2017
Nature of control: 50,01-75% shares
50,01-75% voting rights
right to appoint and remove directors

The deadline for Zarodex Therapeutics Limited confirmation statement filing is 2020-08-02. The previous confirmation statement was filed on 2019-07-19. The target date for a subsequent annual accounts filing is 30 June 2020. Last accounts filing was sent for the time period up to 30 September 2018.

2 persons of significant control are listed in the official register, namely: Houman A. that owns over 1/2 to 3/4 of shares , over 1/2 to 3/4 of voting rights. Duncan M. that owns over 1/2 to 3/4 of shares , over 1/2 to 3/4 of voting rights.

Company filing
Filter filings by category:
Accounts Address Confirmation statement Incorporation Officers
Confirmation statement with no updates 2019/07/19
filed on: 19th, July 2019 | confirmation statement
Free Download (3 pages)